Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Biotechnol Bioeng ; 2023 May 20.
Artículo en Inglés | MEDLINE | ID: mdl-37209384

RESUMEN

Protein A affinity chromatography is an important step in the purification of monoclonal antibodies (mAbs) and mAb-derived biotherapeutics. While the biopharma industry has extensive expertise in the operation of protein A chromatography, the mechanistic understanding of the adsorption/desorption processes is still limited, and scaling up and scaling down can be challenging because of complex mass transfer effects in bead-based resins. In convective media, such as fiber-based technologies, complex mass transfer effects such as film and pore diffusions do not occur which facilitates the study of the adsorption phenomena in more detail and simplifies the process scale-up. In the present study, the experimentation with small-scale fiber-based protein A affinity adsorber units using different flow rates forms the basis for modeling of mAb adsorption and elution behavior. The modeling approach combines aspects of both stoichiometric and colloidal adsorption models, and an empirical part for the pH. With this type of model, it was possible to describe the experimental chromatograms on a small scale very well. An in silico scale-up could be carried out solely with the help of system and device characterization without feedstock. The adsorption model could be transferred without adaption. Although only a limited number of runs were used for modeling, the predictions of up to 37 times larger units were accurate.

2.
Biotechnol Bioeng ; 117(12): 3986-4000, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32725887

RESUMEN

The Third Modeling Workshop focusing on bioprocess modeling was held in Kenilworth, NJ in May 2019. A summary of these Workshop proceedings is captured in this manuscript. Modeling is an active area of research within the biotechnology community, and there is a critical need to assess the current state and opportunities for continued investment to realize the full potential of models, including resource and time savings. Beyond individual presentations and topics of novel interest, a substantial portion of the Workshop was devoted toward group discussions of current states and future directions in modeling fields. All scales of modeling, from biophysical models at the molecular level and up through large scale facility and plant modeling, were considered in these discussions and are summarized in the manuscript. Model life cycle management from model development to implementation and sustainment are also considered for different stages of clinical development and commercial production. The manuscript provides a comprehensive overview of bioprocess modeling while suggesting an ideal future state with standardized approaches aligned across the industry.


Asunto(s)
Biotecnología , Simulación por Computador , Modelos Teóricos
3.
Chemphyschem ; 18(18): 2517-2525, 2017 Sep 20.
Artículo en Inglés | MEDLINE | ID: mdl-28815973

RESUMEN

Intermetallic GaPd2 is a highly selective and stable catalyst for the semi-hydrogenation of acetylene. Knowledge of the underlying reaction kinetics is essential to gain a deeper understanding of the selective hydrogenation on this catalytic material. To date, there has been no experimental kinetic data published for this reaction on a well-defined intermetallic catalyst possessing isolated active sites. Kinetic measurements are performed at 140-200 °C, revealing an apparent activation energy of 29(2) kJ mol-1 . GaPd2 is shown to be the first binary catalyst material, which shows a positive reaction order (0.89) with respect to acetylene at 200 °C. The influences on the extent of acetylene conversion, specific activity and selectivity to ethylene, ethane, and higher hydrocarbons are determined by a 24 factorial experiment following a design of experiments approach. Temperature and pressure have the strongest impact on these values. The results allow optimal operation for achieving high ethylene yields. A comparison of the reaction kinetics on GaPd2 with experimental results obtained for GaPd reveals different orders of reaction of H2 and C2 H2 on the two compounds.

4.
BMC Cancer ; 16: 199, 2016 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-26957307

RESUMEN

BACKGROUND: Alpha-tocopheryloxyacetic acid (α-TEA) is a semi-synthetic derivative of naturally occurring vitamin E (alpha-tocopherol) that can be delivered via an oral route. Preclinical in vitro and in vivo data demonstrated that α-TEA is a potent anti-tumor agent with a safe toxicity profile in mice. We report a comprehensive study to evaluate the toxokinetics of good manufacturing practice (GMP)-grade α-TEA in dogs after daily oral administration for 28 days, followed by a 28-day recovery period. METHODS: Male and female beagle dogs received capsules of α-TEA Lysine Salt at doses of 100, 300, 1500 mg/kg/day. α-TEA plasma levels were determined by high-performance liquid chromatography (HPLC) with mass spectrometric detection. During the treatment, animals were observe for clinical signs, food consumption, body weight, and subjected to ophthalmoscopic, and electrocardiographic assessments. At the end of the dosing period, blood was taken and toxicokinetic analyses and histopathology assessments were performed when animals were necropsied. RESULTS: Our findings showed that there was no α-TEA-related mortality or moribundity. At the highest dose, increases in white blood cells and fibrinogen levels were observed. These levels returned to normal at the end of the recovery period. Histopathological evaluation of major organs revealed no significant lesions related to α-TEA-treatment. CONCLUSION: We demonstrate that for designing clinical trials in patients, the highest non-severely toxic dose (HNSTD) of α-TEA is 1500 mg/kg/day in Beagle dogs and this data informed the design of dose-escalation studies of α-TEA in patients with advanced cancer.


Asunto(s)
Tocoferoles/farmacocinética , Tocoferoles/toxicidad , Administración Oral , Animales , Antineoplásicos/administración & dosificación , Antineoplásicos/química , Antineoplásicos/farmacocinética , Antineoplásicos/toxicidad , Biopsia , Recuento de Células Sanguíneas , Análisis Químico de la Sangre , Coagulación Sanguínea/efectos de los fármacos , Pruebas de Coagulación Sanguínea , Perros , Femenino , Lisina , Masculino , Sales (Química) , Factores de Tiempo , Tocoferoles/administración & dosificación , Tocoferoles/química , Pruebas de Toxicidad , Toxicocinética , Urinálisis
5.
Biotechnol Bioeng ; 112(10): 2123-33, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25988478

RESUMEN

Upstream processes are rather complex to design and the productivity of cells under suitable cultivation conditions is hard to predict. The method of choice for examining the design space is to execute high-throughput cultivation screenings in micro-scale format. Various predictive in silico models have been developed for many downstream processes, leading to a reduction of time and material costs. This paper presents a combined optimization approach based on high-throughput micro-scale cultivation experiments and chromatography modeling. The overall optimized system must not necessarily be the one with highest product titers, but the one resulting in an overall superior process performance in up- and downstream. The methodology is presented in a case study for the Cherry-tagged enzyme Glutathione-S-Transferase from Escherichia coli SE1. The Cherry-Tag™ (Delphi Genetics, Belgium) which can be fused to any target protein allows for direct product analytics by simple VIS absorption measurements. High-throughput cultivations were carried out in a 48-well format in a BioLector micro-scale cultivation system (m2p-Labs, Germany). The downstream process optimization for a set of randomly picked upstream conditions producing high yields was performed in silico using a chromatography modeling software developed in-house (ChromX). The suggested in silico-optimized operational modes for product capturing were validated subsequently. The overall best system was chosen based on a combination of excellent up- and downstream performance.


Asunto(s)
Productos Biológicos/aislamiento & purificación , Productos Biológicos/metabolismo , Biotecnología/métodos , Cromatografía/métodos , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Ensayos Analíticos de Alto Rendimiento , Colorimetría , Genes Reporteros , Glutatión Transferasa/aislamiento & purificación , Glutatión Transferasa/metabolismo , Proteínas Recombinantes de Fusión/aislamiento & purificación , Proteínas Recombinantes de Fusión/metabolismo
6.
Magn Reson Med ; 71(1): 302-7, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23400935

RESUMEN

PURPOSE: To develop MR based real-time gastrointestinal 19-Fluorine (19F) catheter tracking and visualization allowing for real-time detection and feedback of 3D catheter shape and movement as well as catheter-driven adjustments of 1H imaging geometry parameters. METHODS: Data were acquired on a 3T clinical system using 3D Golden Angle radial sampling. Two gastrointestinal catheters incorporating four fiducial 19F markers (65 or 50 µL marker volume) were tracked while being pulled through a gel phantom by an operator inside the MR room with velocities of 2-18 mm/s. During continuous acquisition, k-space profiles were transferred in real-time to an external computer for concurrent reconstruction of 3D 19F images and detection and visualization of marker positions. Based on αthe marker positions, automatic adjustments of 1H imaging planes to facilitate targeted anatomical scanning was implemented. RESULTS: Mean tracking reliabilities were 94.5 and 83.6% (catheters 1 and 2) for temporal resolutions 185-740 ms. Reconstruction times of 196 ms were achieved. Real-time visual feedback allowed the operator to accurately control the catheter movement. Catheter-guidance for 1H imaging was reliable. CONCLUSION: The presented real-time 19F MR based framework for the tracking of 19F labeled devices is applicable to combined 19F and 1H MRI guidance of gastrointestinal devices in vivo.


Asunto(s)
Cateterismo/métodos , Flúor , Tracto Gastrointestinal/anatomía & histología , Interpretación de Imagen Asistida por Computador/métodos , Imagen por Resonancia Magnética Intervencional/métodos , Sistemas de Computación , Medios de Contraste , Humanos , Imagen por Resonancia Magnética Intervencional/instrumentación , Fantasmas de Imagen , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
7.
Biotechnol Prog ; 39(2): e3316, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36471899

RESUMEN

Mixed-mode chromatography combines features of ion-exchange chromatography and hydrophobic interaction chromatography and is increasingly used in antibody purification. As a replacement for flow-through operations on traditional unmixed resins or as a pH-controlled bind-and-elute step, the use of both interaction modes promises a better removal of product-specific impurities. However, the combination of the functionalities makes industrial process development significantly more complex, in particular the identification of the often small elution window that delivers the desired selectivity. Mechanistic modeling has proven that even difficult separation problems can be solved in a computer-optimized manner once the process dynamics have been modeled. The adsorption models described in the literature are also very complex, which makes model calibration difficult. In this work, we approach this problem with a newly constructed model that describes the adsorber saturation with the help of the surface coverage function of the colloidal particle adsorption model for ion-exchange chromatography. In a case study, a model for a pH-controlled antibody polishing step was created from six experiments. The behavior of fragments, aggregates, and host cell proteins was described with the help of offline analysis. After in silico optimization, a validation experiment confirmed an improved process performance in comparison to the historical process set point. In addition to these good results, the work also shows that the high dynamics of mixed-mode chromatography can produce unexpected results if process parameters deviate too far from tried and tested conditions.


Asunto(s)
Anticuerpos Monoclonales , Anticuerpos Monoclonales/química , Cromatografía por Intercambio Iónico/métodos
8.
PLoS One ; 18(5): e0285492, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37141251

RESUMEN

OBJECTIVES: Sonic/ultrasonic devices are essential tools in today's endodontics. This prospective trial evaluated for the first time the impact of practitioners' proficiency levels and patient-related factors on complications associated with a high frequency polyamide sonic irrigant activation device. METHODS: In total 334 patients (females:158, males:176; age:18-95 years) received in the course of their endodontic therapy an intracanal irrigation, using a high frequency polyamide sonic irrigant activation device, by practitioners of different proficiency levels (undergraduate students, general practitioners or endodontists). Intracanal bleeding (yes/no), postoperative pain (0-10 scale), emphysema (yes/no) and polyamide tip fractures (yes/no) were recorded and related to proficiency levels, age, gender, tooth type, smoking-status, systemic conditions affecting healing ability, baseline pain, swelling, fistula, sensitivity to percussion and diagnosis. RESULTS: Intracanal bleeding was associated with patients' age (p<0.05), baseline pain level (OR = 1.14, 95%CI = 0.91-1.22) and baseline swelling (OR = 2.73, 95%CI = 0.14-0.99; p<0.05) but not proficiency level, gender, tooth type, smoking, systemic conditions, baseline fistula or sensitivity to percussion (p>0.05). Postoperative pain development was related to proficiency level (p<0.05) and baseline pain level (p<0.001), with no influence of age, gender, tooth type, smoking, systemic conditions, baseline fistula, swelling or sensitivity to percussion (p>0.05). Emphysema and polyamide tip fractures were not reported. CONCLUSIONS: Within the current study's limitations, younger patients with higher baseline pain and swelling, were associated with higher intracanal bleeding. Apart from higher postoperative pain observed with less experienced practitioners, proficiency level had no influence on bleeding, polyamide tip fracture or emphysema, endorsing the high frequency polyamide sonic irrigation device as a safe therapeutic device.


Asunto(s)
Enfisema , Nylons , Masculino , Femenino , Humanos , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Estudios Prospectivos , Estudios de Cohortes , Irrigantes del Conducto Radicular , Irrigación Terapéutica/efectos adversos , Dolor Postoperatorio
9.
Cancer Immunol Immunother ; 61(4): 511-21, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21971588

RESUMEN

Effective tumor immunotherapy may require not only activation of anti-tumor effector cells, but also abrogation of tumor-mediated immunosuppression. The cytokine TGF-ß, is frequently elevated in the tumor microenvironment and is a potent immunosuppressive agent and promoter of tumor metastasis. OX40 (CD134) is a member of the TNF-α receptor superfamily and ligation by agonistic antibody (anti-OX40) enhances effector function, expansion, and survival of activated T cells. In this study, we examined the therapeutic efficacy and anti-tumor immune response induced by the combination of a small molecule TGF-ß signaling inhibitor, SM16, plus anti-OX40 in the poorly immunogenic, highly metastatic, TGF-ß-secreting 4T1 mammary tumor model. Our data show that SM16 and anti-OX40 mutually enhanced each other to elicit a potent anti-tumor effect against established primary tumors, with a 79% reduction in tumor size, a 95% reduction in the number of metastatic lung nodules, and a cure rate of 38%. This positive treatment outcome was associated with a 3.2-fold increase of tumor-infiltrating, activated CD8+ T cells, an overall accumulation of CD4+ and CD8+ T cells, and an increased tumor-specific effector T cell response. Complete abrogation of the therapeutic effect in vivo following depletion of CD4+ and CD8+ T cells suggests that the anti-tumor efficacy of SM16+ anti-OX40 therapy is T cell dependent. Mice that were cured of their tumors were able to reject tumor re-challenge and manifested a significant tumor-specific peripheral memory IFN-γ response. Taken together, these data suggest that combining a TGF-ß signaling inhibitor with anti-OX40 is a viable approach for treating metastatic breast cancer.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Compuestos de Azabiciclo/administración & dosificación , Carcinoma/tratamiento farmacológico , Inmunoterapia , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Factor de Crecimiento Transformador beta/antagonistas & inhibidores , Animales , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales/efectos adversos , Compuestos de Azabiciclo/efectos adversos , Carcinoma/patología , Progresión de la Enfermedad , Sinergismo Farmacológico , Femenino , Neoplasias Mamarias Experimentales/patología , Ratones , Ratones Endogámicos BALB C , Metástasis de la Neoplasia , Trasplante de Neoplasias , Receptores OX40/agonistas , Receptores OX40/inmunología , Transducción de Señal/efectos de los fármacos , Carga Tumoral
10.
Radiology ; 265(3): 917-25, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22996747

RESUMEN

PURPOSE: To combine fluorine 19 ((19)F) magnetic resonance (MR) imaging and golden angle radial acquisition and to assess the feasibility of (19)F MR imaging golden angle-based tracking for catheter tracking applications and simultaneous three-dimensional (3D) intestinal tracking of ingested (19)F-labeled capsules in vivo. MATERIALS AND METHODS: Approval from the local ethical committee and informed consent from the subject were obtained. In vitro studies were performed to assess (19)F MR imaging golden angle-based tracking reliability with regard to temporal resolution and different tracking strategies (boundary condition-free tracking, composite image-based tracking, and model-based tracking). In vivo performance of the method was investigated in one healthy volunteer on 2 days. On study day 1, a duodenal catheter incorporating five (19)F-labeled capsules was administered nasally, and its 3D movement was tracked inside the stomach and esophagus. On study day 2, three (19)F-labeled capsules were swallowed, and intestinal movement was tracked. RESULTS: Simultaneous in vivo 3D tracking of multiple (19)F-labeled capsules was successfully performed without incorporation of boundary conditions at a temporal resolution of 252 msec. Incorporation of boundary conditions with composite image-based tracking and model-based tracking increased tracking reliability and enabled temporal resolution as high as 108 msec. CONCLUSION: Use of (19)F MR imaging golden angle-based capsule tracking enables in vivo tracking of (19)F-labeled capsules and catheters at high temporal resolution. The presented method is applicable to physioanatomic studies of the gastrointestinal tract and shows potential for real-time tracking in interventional radiology.


Asunto(s)
Cápsulas , Cateterismo , Motilidad Gastrointestinal/fisiología , Tránsito Gastrointestinal/fisiología , Imagen por Resonancia Magnética Intervencional/métodos , Algoritmos , Materiales Biocompatibles Revestidos , Éteres Corona , Estudios de Factibilidad , Fluorocarburos , Humanos , Procesamiento de Imagen Asistido por Computador , Imagenología Tridimensional , Reproducibilidad de los Resultados , Relación Señal-Ruido
11.
Anticancer Drugs ; 23(4): 455-64, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22185820

RESUMEN

Alpha-tocopheryloxy acetic acid (α-TEA) is an ether derivative of vitamin E and has been shown to suppress tumor growth in various murine and human xenograft tumor models, including melanoma, breast, lung, prostate, and ovarian cancers. The purpose of this study was to assess its safety and pharmacokinetics after repeat dosing in a preclinical murine model. Male and female mice received α-TEA doses of 100, 300, or 1500 mg/kg/day by daily oral gavage for 28 days. α-TEA serum levels were determined weekly by high-performance liquid chromatography with mass spectrometric detection. After 28 days of dosing, complete blood counts were taken, blood chemistry was analyzed, and histology was performed. Pharmacokinetic parameters were determined after single dosing. There was no mortality, and we found no clinical signs of toxicity in any of the α-TEA doses tested. Histopathological evaluation of major organs (heart, lung, kidney, liver, spleen, jejunum, ileum, and cecum) revealed no significant α-TEA treatment-related lesions. Blood counts revealed low-grade anemia but no other significant differences between treatment and control groups. Blood chemistry revealed moderate liver toxicity that was dose dependent and was absent in the lowest dose group. There were no significant sex-specific differences in the toxicity profile. The half-life of orally administered α-TEA was determined to be 52 h. This is the first report comprehensively evaluating the toxicity profile of this novel anticancer drug and will facilitate the design of clinical trials to evaluate the safety and antitumor efficacy of α-TEA in patients with cancer.


Asunto(s)
Antineoplásicos/farmacocinética , Tocoferoles/farmacocinética , Anemia/inducido químicamente , Animales , Antineoplásicos/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas , Evaluación Preclínica de Medicamentos , Femenino , Masculino , Ratones , Ratones Endogámicos BALB C , Tocoferoles/toxicidad
12.
Breast Cancer Res ; 13(1): R4, 2011 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-21232138

RESUMEN

INTRODUCTION: α-Tocopheryloxyacetic acid (α-TEA) is a novel ether derivative of α-tocopherol that has generated interest as a chemotherapeutic agent because of its selective toxicity toward tumor cells and its ability to suppress tumor growth in various rodent and human xenograft models. We previously reported that oral α-TEA inhibited the growth of both a transplanted (4T1) and a spontaneous MMTV-PyMT mouse model of breast cancer. METHODS: Because little is known about the possible immunological mechanisms underlying the in vivo α-TEA effects, we evaluated the impact of α-TEA therapy on the immune response by characterizing immune cell populations infiltrating the tumor site. RESULTS: α-TEA treatment resulted in higher frequencies of activated T cells in the tumor microenvironment and twofold and sixfold higher ratios of CD4⁺ and CD8⁺T cells to regulatory T cells, respectively. This finding was correlated with an increased ability of tumor-draining lymph node cells and splenocytes from α-TEA-treated mice to secrete interferon (IFN)-γ in response to CD3 or to mediate a cytolytic response in a tumor-specific fashion, respectively. That the α-TEA-mediated antitumor effect had a T cell-dependent component was demonstrated by the partial abrogation of tumor suppression when CD4⁺ and CD8⁺ T cells were depleted. We also determined the intratumoral cytokine and chemokine profile and found that α-TEA treatment increased intratumoral IFN-γ levels but decreased interleukin (IL)-4 levels, suggesting a shift toward a TH1 response. In addition, α-TEA induced higher levels of the inflammatory cytokine IL-6 and the chemokine CCL5. CONCLUSIONS: Taken together, these data suggest that α-TEA treatment, in addition to its direct cytotoxic effects, enhanced the anti-tumor immune response. This study provides a better understanding of the mechanisms of action of α-TEA and its effect on the immune system and may prove useful in designing immune-stimulating strategies to boost the antitumor effects of α-TEA in breast cancer patients.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias Mamarias Experimentales/inmunología , Tocoferoles/farmacología , Administración Oral , Animales , Antineoplásicos/administración & dosificación , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Citocinas/inmunología , Citotoxicidad Inmunológica/efectos de los fármacos , Femenino , Estimación de Kaplan-Meier , Ganglios Linfáticos/efectos de los fármacos , Ganglios Linfáticos/metabolismo , Activación de Linfocitos/efectos de los fármacos , Linfocitos Infiltrantes de Tumor/efectos de los fármacos , Linfocitos Infiltrantes de Tumor/inmunología , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Linfocitos T Reguladores/efectos de los fármacos , Linfocitos T Reguladores/inmunología , Tocoferoles/administración & dosificación , Microambiente Tumoral/efectos de los fármacos , Microambiente Tumoral/inmunología
13.
Magn Reson Med ; 66(3): 812-20, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21381105

RESUMEN

A combined (19)F and (1)H MRI framework for the assessment of human intestinal transit and motor function is presented. This framework consists of silicone coated polychlorotrifluoroethylene capsules filled with perfluoro-[15]-crown-5-ether as (19)F marker, a flexible (19)F surface coil and a (19)F projection imaging sequence, allowing for real-time tracking of a single or multiple capsules. The capsules (length 11.5 mm, Ø 7.2 mm) contain 140 µL perfluoro-[15]-crown-5-ether and were tested for cytotoxicity and leakage prior to oral administration. A balanced SSFP projection sequence was implemented, yielding a temporal resolution of 133 ms. Optional multi-frequency excitation, allowing for interleaved tracking of differently labeled (19)F capsules, was incorporated. The passage of the (19)F capsules through intestinal sections was monitored in two healthy volunteers. Capsule coordinates were successfully coregistered with anatomical reference scans. Intestinal motility, residence times, lengths and forward velocities were determined. Simultaneous tracking of two capsules allowed for the assessment of peristaltic patterns with correction for respiratory motion. By providing the means for real-time multiple capsule tracking and high resolution anatomical imaging, the presented multinuclear imaging framework has the potential to provide important supplemental information for physiological and pharmaceutical research.


Asunto(s)
Cápsulas , Motilidad Gastrointestinal/fisiología , Tránsito Gastrointestinal/fisiología , Imagen por Resonancia Magnética/métodos , Materiales Biocompatibles Revestidos , Éteres Corona , Estudios de Factibilidad , Flúor , Humanos , Procesamiento de Imagen Asistido por Computador , Polietilenos , Siliconas
14.
BMC Cancer ; 11: 471, 2011 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-22044845

RESUMEN

BACKGROUND: HER2/neu is an oncogene that facilitates neoplastic transformation due to its ability to transduce growth signals in a ligand-independent manner, is over-expressed in 20-30% of human breast cancers correlating with aggressive disease and has been successfully targeted with trastuzumab (Herceptin®). Because trastuzumab alone achieves only a 15-30% response rate, it is now commonly combined with conventional chemotherapeutic drugs. While the combination of trastuzumab plus chemotherapy has greatly improved response rates and increased survival, these conventional chemotherapy drugs are frequently associated with gastrointestinal and cardiac toxicity, bone marrow and immune suppression. These drawbacks necessitate the development of new, less toxic drugs that can be combined with trastuzumab. Recently, we reported that orally administered alpha-tocopheryloxyacetic acid (α-TEA), a novel ether derivative of alpha-tocopherol, dramatically suppressed primary tumor growth and reduced the incidence of lung metastases both in a transplanted and a spontaneous mouse model of breast cancer without discernable toxicity. METHODS: In this study we examined the effect of α-TEA plus HER2/neu-specific antibody treatment on HER2/neu-expressing breast cancer cells in vitro and in a HER2/neu positive human xenograft tumor model in vivo. RESULTS: We show in vitro that α-TEA plus anti-HER2/neu antibody has an increased cytotoxic effect against murine mammary tumor cells and human breast cancer cells and that the anti-tumor effect of α-TEA is independent of HER2/neu status. More importantly, in a human breast cancer xenograft model, the combination of α-TEA plus trastuzumab resulted in faster tumor regression and more tumor-free animals than trastuzumab alone. CONCLUSION: Due to the cancer cell selectivity of α-TEA, and because α-TEA kills both HER2/neu positive and HER2/neu negative breast cancer cells, it has the potential to be effective and less toxic than existing chemotherapeutic drugs when used in combination with HER2/neu antibody.


Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Antineoplásicos/uso terapéutico , Antioxidantes/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Tocoferoles/farmacología , Animales , Western Blotting , Neoplasias de la Mama/metabolismo , Línea Celular Tumoral/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Sinergismo Farmacológico , Femenino , Citometría de Flujo , Humanos , Ratones , Modelos Biológicos , Fragmentos de Péptidos/metabolismo , Trastuzumab
15.
Med Phys ; 38(11): 5998-6009, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22047364

RESUMEN

PURPOSE: Although breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) demonstrates high sensitivity for malignant tumor detection, a major limitation is the relative low specificity, resulting in many false-positive diagnoses of suspicious lesions (BI-RADS assessment of 4 or 5) in clinical practice and consequently producing a relatively low positive predictive value (PPV) for biopsies. The most enhanced areas in the malignant tumors show a typical washout (WO) kinetic feature for the postcontrast signal intensity time courses and also correlate with microvessel density. Benign proliferative breast diseases can also produce the WO curve, yielding an equivocal kinetic behavior for the benign lesions and rendering their diagnoses as suspicious lesions in clinical practice. Considering that tumor angiogenesis is essential to an aggressive cancer tumor growth, the authors hypothesize that the WO volume fraction, i.e., the total volume of the WO voxels that demonstrate the WO curve within the tumor, is relatively large for malignant tumors in comparison to that for benign lesions. In this study, the authors present a lesion fractional volume WO kinetic analysis for improving the characterization of suspicious breast lesions. METHODS: A method to automatically detect the boundary of a manually selected contrast-enhanced lesion was introduced and tested, utilizing the signal intensity difference between the contrast-enhanced lesion and its surrounding tissues. The kinetic features of the postcontrast signal intensity time courses were quantitatively analyzed voxel-by-voxel with emphasis on the examination of the WO behavior. The WO volume fraction relative to the whole lesion volume was introduced and tested as a biomarker for improving the characterization of suspicious breast lesions. The sample for this test consisted of 28 suspicious lesions with correlative histopathology reports available. The lesions included 10 malignant tumors and 18 benign lesions, yielding a 35.7% PPV of the biopsies. RESULTS: The semi-automatic method produced an objective volume of interest for each lesion with voxelwise-quantified kinetic features. With an optimal choice of kinetic analysis, the mean and standard deviation of the WO volume fraction were 59.1 ± 13.1 (%) with the range from 41.0% to 80.7% for the malignant tumors and 31.4 ± 20.5 (%) with the range between 3.3% and 71.6% for the benign lesions, respectively. The WO volume fraction was significantly larger (p < 0.0004) for the malignant tumors than for the benign lesions. While maintaining the same sensitivity for malignant tumors, using the WO volume fraction as an additional biomarker would characterize 14 out of the 18 benign lesions as benign, potentially resulting in an 100% improvement rate in the PPV of the biopsies (from 35.7% to 71.4%) and consequently a 77.8% reduction rate in potentially unnecessary biopsies (from 18 to 4). CONCLUSIONS: The significantly larger WO volume fraction for the malignant tumors was probably related to the increased vascularity associated with tumor angiogenesis. The results suggest that the WO volume fraction biomarker has potential to improve the computer-based assessment of breast MRI by greatly increasing the PPV of breast biopsies and potentially significantly reducing the number of unnecessary biopsies without compromising sensitivity.


Asunto(s)
Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/metabolismo , Medios de Contraste/farmacocinética , Imagen por Resonancia Magnética/métodos , Adulto , Automatización , Femenino , Humanos , Cinética , Factores de Tiempo
16.
J Chromatogr A ; 1653: 462397, 2021 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-34284263

RESUMEN

For mechanistic modeling of ion exchange (IEX) processes, a profound understanding of the adsorption mechanism is important. While the description of protein adsorption in IEX processes has been dominated by stoichiometric models like the steric mass action (SMA) model, discrepancies between experimental data and model results suggest that the conceptually simple stoichiometric description of protein adsorption provides not always an accurate representation of nonlinear adsorption behavior. In this work an alternative colloidal particle adsorption (CPA) model is introduced. Based on the colloidal nature of proteins, the CPA model provides a non-stoichiometric description of electrostatic interactions within IEX columns. Steric hindrance at the adsorber surface is considered by hard-body interactions between proteins using the scaled-particle theory. The model's capability of describing nonlinear protein adsorption is demonstrated by simulating adsorption isotherms of a monoclonal antibody (mAb) over a wide range of ionic strength and pH. A comparison of the CPA model with the SMA model shows comparable model results in the linear adsorption range, but significant differences in the nonlinear adsorption range due to the different mechanistic interpretation of steric hindrance in both models. The results suggest that nonlinear adsorption effects can be overestimated by the stoichiometric formalism of the SMA model and are generally better reproduced by the CPA model.


Asunto(s)
Intercambio Iónico , Modelos Químicos , Proteínas , Adsorción , Cromatografía por Intercambio Iónico , Proteínas/química , Proteínas/aislamiento & purificación , Electricidad Estática
17.
J Chromatogr A ; 1654: 462439, 2021 Sep 27.
Artículo en Inglés | MEDLINE | ID: mdl-34384923

RESUMEN

A fundamental understanding of the protein retention mechanism in preparative ion exchange (IEX) chromatography columns is essential for a model-based process development approach. For the past three decades, the mechanistic description of protein retention has been based predominantly on the steric mass action (SMA) model. In recent years, however, retention profiles of proteins have been reported more frequently for preparative processes that are not consistent with the mechanistic understanding relying on the SMA model. In this work, complex elution behavior of proteins in preparative IEX processes is analyzed using a colloidal particle adsorption (CPA) model. The CPA model is found to be capable of reproducing elution profiles that cannot be described by the traditional SMA model. According to the CPA model, the reported complex behavior can be ascribed to a strong compression and concentration of the elution front in the lower unsaturated part of the chromatography column. As the unsaturated part of the column decreases with increasing protein load density, exceeding a critical load density can lead to the formation of a shoulder in the peak front. The general applicability of the model in describing preparative IEX processes is demonstrated using several industrial case studies including multiple monoclonal antibodies on different IEX adsorber systems. In this context, the work covers both salt controlled and pH-controlled protein elution.


Asunto(s)
Anticuerpos Monoclonales , Cromatografía por Intercambio Iónico , Modelos Químicos , Proteínas , Adsorción , Proteínas/química , Proteínas/aislamiento & purificación
18.
Nat Commun ; 12(1): 1929, 2021 03 26.
Artículo en Inglés | MEDLINE | ID: mdl-33771987

RESUMEN

Leigh syndrome (LS) is a severe manifestation of mitochondrial disease in children and is currently incurable. The lack of effective models hampers our understanding of the mechanisms underlying the neuronal pathology of LS. Using patient-derived induced pluripotent stem cells and CRISPR/Cas9 engineering, we developed a human model of LS caused by mutations in the complex IV assembly gene SURF1. Single-cell RNA-sequencing and multi-omics analysis revealed compromised neuronal morphogenesis in mutant neural cultures and brain organoids. The defects emerged at the level of neural progenitor cells (NPCs), which retained a glycolytic proliferative state that failed to instruct neuronal morphogenesis. LS NPCs carrying mutations in the complex I gene NDUFS4 recapitulated morphogenesis defects. SURF1 gene augmentation and PGC1A induction via bezafibrate treatment supported the metabolic programming of LS NPCs, leading to restored neuronal morphogenesis. Our findings provide mechanistic insights and suggest potential interventional strategies for a rare mitochondrial disease.


Asunto(s)
Células Madre Pluripotentes Inducidas/metabolismo , Enfermedad de Leigh/genética , Proteínas de la Membrana/genética , Proteínas Mitocondriales/genética , Mutación , Neuronas/metabolismo , Organoides/metabolismo , Células Cultivadas , Preescolar , Humanos , Células Madre Pluripotentes Inducidas/citología , Enfermedad de Leigh/metabolismo , Masculino , Metabolómica/métodos , Mitocondrias/genética , Mitocondrias/metabolismo , Morfogénesis/genética , Neuronas/citología , Proteómica/métodos , Análisis de la Célula Individual/métodos , Secuenciación del Exoma
19.
J Environ Manage ; 91(10): 1997-2007, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20570034

RESUMEN

In this paper, we propose the return-to-cost-ratio (RCR) as an alternative approach to the analysis of operational eco-efficiency of companies based on the notion of opportunity costs. RCR helps to overcome two fundamental deficits of existing approaches to eco-efficiency. (1) It translates eco-efficiency into managerial terms by applying the well-established notion of opportunity costs to eco-efficiency analysis. (2) RCR allows to identify and quantify the drivers behind changes in corporate eco-efficiency. RCR is applied to the analysis of the CO(2)-efficiency of German companies in order to illustrate its usefulness for a detailed analysis of changes in corporate eco-efficiency as well as for the development of effective environmental strategies.


Asunto(s)
Dióxido de Carbono/análisis , Conservación de los Recursos Naturales , Contaminación Ambiental/prevención & control , Dióxido de Carbono/química , Costos y Análisis de Costo , Alemania
20.
J Chromatogr A ; 1611: 460608, 2020 Jan 25.
Artículo en Inglés | MEDLINE | ID: mdl-31629491

RESUMEN

Mechanistic modeling of protein adsorption has gained increasing importance in the development of ion-exchange (IEX) chromatography processes. The most common adsorption models use a stoichiometric representation of the adsorption process based on the law of mass action. Despite the importance of these models in model-based development, the stoichiometric representation of the adsorption process is not accurate for the description of long-range electrostatic interactions in IEX chromatography, limiting the application and mechanistic extension of these models. In this work an adsorption model is introduced describing the non-stoichiometric electrostatic interaction in IEX chromatography based on the linear Poisson-Boltzmann equation and a simplified colloidal representation of the protein. In contrast to most recent non-stoichiometric models, the introduced model accounts for charge regulation during the adsorption process. Its capability of describing the adsorption equilibrium is demonstrated by simulating partitioning coefficients of multiple proteins on different adsorber systems as a function of ionic strength and pH. Despite model simplifications the physical meaning and predictive value of the model could be preserved. By transferring model parameters of a monoclonal antibody (mAb) from one adsorber system to another, it could be demonstrated that protein parameters are theoretically not only valid on a specific adsorber system but freely transferable to other adsorbers. The predictive value of the mechanistic model on the new adsorber system was highlighted by predicting the elution behavior of charge variants of the mAb.


Asunto(s)
Cromatografía por Intercambio Iónico/métodos , Coloides/química , Proteínas/química , Electricidad Estática , Adsorción , Ligandos , Isoformas de Proteínas/química , Programas Informáticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA